Law Offices of Frank R. Cruz Encourages 3D Systems Corporation (DDD) Investors To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased 3D Systems Corporation ('3D Systems' or the 'Company') (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the 'Class Period'). 3D Systems investors have until to file a lead plaintiff motion.
Law Offices of Frank R. Cruz Encourages 3D Systems Corporation (DDD) Investors To Inquire About Securities Fraud Class Action
Share
IF YOU SUFFERED A LOSS ON YOUR 3D SYSTEMS CORPORATION (DDD) INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT.
You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at info@frankcruzlaw.com, by telephone at (310) 914-5007, or visit our website at www.frankcruzlaw.com.
What Happened?
On March 26, 2025, 3D Systems released its fourth quarter and full year 2024 financial results, missing consensus estimates in non-GAAP earnings-per-share and sales revenue, citing 'lowers hardware systems sales due to macroeconomic factors that are negatively impacting demand.' The Company also reported a '$9 million revenue reduction in Q4 driven by a change in accounting estimates for [the Company's] Regenerative Medicine program." The Company disclosed that "[t]his change in estimate [was] related to the now anticipated use of pre-clinical human decedent testing . . . which led to refinement of the milestone technical criteria."
On this news, 3D Systems' stock price fell $0.57, or 21%, to close at $2.15 per share on March 27, 2025, thereby injuring investors.
Then, on May 12, 2025, after market hours, 3D Systems released its first quarter 2025 financial results, missing consensus estimates due, in part, to a decline in material sales, mostly due to inventory management issues in the dental portion of its Healthcare Solutions segment. The Company further disclosed that it was withdrawing its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty.
On this news, 3D Systems' stock price fell $0.68, or 26.6%, to close at $1.87 per share on May 13, 2025, thereby injuring investors further.
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) 3D Systems had understated the impact of weakened customer spending on the Company's business, while overstating its resilience in challenging industry conditions; (2) the updated milestone criteria in the United Partnership would negatively impact the Company's Regenerative Medicine Program revenue; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More:
If you purchased 3D Systems securities, wish to learn more about this action, or have any questions concerning this announcement or your rights or interests with respect to these matters, please click HERE or contact us at:
Law Offices of Frank R. Cruz
2121 Avenue of the Stars, Suite 800
Telephone: 310-914-5007
Email: info@frankcruzlaw.com
Visit our website at: www.frankcruzlaw.com
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Morgan Stanley Maintains Coca-Cola (KO) Price Target and Buy Rating
The Coca-Cola Company (NYSE:KO) is one of . Morgan Stanley has elevated The Coca-Cola Company (NYSE:KO) to its top pick within the beverages sector, while maintaining an Overweight rating and setting a price target of $81. The firm's optimism is rooted in Coca-Cola's consistent ability to deliver organic sales growth that surpasses both its peers and market expectations. In a recent research note, Morgan Stanley highlighted several factors driving this positive outlook. The company's strong pricing power stands out, allowing it to maintain healthy margins despite inflationary pressures. Additionally, The Coca-Cola Company (NYSE:KO) continues to see steady volume growth, reflecting ongoing consumer demand across key markets. The analyst also pointed to the company's sustained gains in market share and the relatively calm competitive landscape, which together provide a favorable backdrop for continued growth. Morgan Stanley emphasized that investors can acquire Coca-Cola shares at a valuation comparable to its peers but with the benefit of significantly higher long-term organic sales growth. This combination of robust fundamentals and attractive valuation underpins Morgan Stanley's confidence in Coca-Cola's prospects. The firm believes that Coca-Cola's durable growth trajectory makes it a compelling choice for investors seeking stable returns in the beverage industry. Following the announcement, Coca-Cola's shares showed steady trading, supported by the positive analyst sentiment. While we acknowledge the potential of KO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KO and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: and 10 Best Wide Moat Dividend Stocks to Invest in. Disclosure: None. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Jefferies Trims Clorox (CLX) Price Target, Maintains Buy Rating
The Clorox Company (NYSE:CLX) is one of . Jefferies has adjusted its price target on The Clorox Company (NYSE:CLX) to $145 from $167, while maintaining a Buy rating on the stock. In its latest research note, the firm warned that the next two quarters 'will be complicated to model' due to 'shipping timing ahead of Clorox's U.S. ERP rollout and wind down' which is expected to impact margins through unexpected swings in operating leverage. clay-banks-kBaf0DwBPbE-unsplash Analysts at Jefferies anticipate Clorox's upcoming guidance will reflect a drop of between 2% and 4% in organic sales, coupled with a low-teens percentage decline in EPS for FY26. Cautioning investors, they noted that 'numbers are too high,' recommending a 'recalibration' of consensus estimates. Despite these near-term challenges, Jefferies retains confidence in Clorox's long-term strengths. The firm views the company's strong consumer staples portfolio and established brand as sufficient to weather temporary operational disruptions. While acknowledging potential volatility in the quarters ahead, Jefferies believes that once the ERP implementation settles, The Clorox Company (NYSE:CLX) will return to a more stable growth trajectory. Investors are advised to brace for 'operating leverage and deleverage that surprises' during the transition period, but remain optimistic about management's ability to manage through the upheaval and eventually deliver on its core fundamentals. While we acknowledge the potential of CLX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CLX and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: and 10 Best Wide Moat Dividend Stocks to Invest in. Disclosure: None. Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
Greenbrier (GBX) Reports Earnings Tomorrow: What To Expect
Rail transportation company Greenbrier (NYSE:GBX) will be announcing earnings results this Tuesday after market hours. Here's what to look for. Greenbrier missed analysts' revenue expectations by 15.2% last quarter, reporting revenues of $762.1 million, down 11.7% year on year. It was a disappointing quarter for the company, with full-year revenue guidance missing analysts' expectations significantly and a significant miss of analysts' adjusted operating income estimates. Is Greenbrier a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Greenbrier's revenue to decline 4.2% year on year to $785.7 million, improving from the 21% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.99 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Greenbrier has missed Wall Street's revenue estimates three times over the last two years. Looking at Greenbrier's peers in the heavy machinery segment, only Lindsay has reported results so far. It beat analysts' revenue estimates by 4.6%, delivering year-on-year sales growth of 21.7%. The stock traded up 3.9% on the results. Read our full analysis of Lindsay's earnings results here. There has been positive sentiment among investors in the heavy machinery segment, with share prices up 7.2% on average over the last month. Greenbrier is up 6.8% during the same time and is heading into earnings with an average analyst price target of $49 (compared to the current share price of $47.72). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. 登入存取你的投資組合
